Enzymatica publ AB (ENZY) — Capital Reinvestment Ratio

Latest as of March 2021: 2.69x

Enzymatica publ AB (ENZY) has a Capital Reinvestment Ratio of 2.69x as of March 2021, meaning it reinvests 3% of its operating cash flow (Skr1.32 Million) in capital expenditures (Skr3.55 Million). See Enzymatica publ AB balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

2.69x
Capex / Operating Cash Flow

Operating Cash Flow

Skr1.32 Million
SEK

Capital Expenditures

Skr3.55 Million
SEK

Data as of

Mar 2021
Most recent filing

Annual Capital Reinvestment Ratio for Enzymatica publ AB (None–None)

Year-by-year Capital Reinvestment Ratio for Enzymatica publ AB from None to None. For live market cap and broader valuation context, see Enzymatica publ AB market cap and net worth.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow